OVARIAN CANCER RESEARCH FUND INC: Form 990, tax year 2025

View the entire original 990 at ProPublica ↗

Organization
OVARIAN CANCER RESEARCH FUND INC (EIN 13-3806788)
Tax period
2025-01-01 to 2025-12-31
Filed
2026-09-11
IRS object ID
202602549349301565
Schema version
2025v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2026-09-11T15:16:17-05:00ReturnTs
Tax Period End2025-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN331374517PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1PKF O'CONNOR DAVIES ADVISORY LLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1500 MAMARONECK AVENUE SUITE 301AddressLine1Txt
CityHARRISONCityNm
State AbbreviationNYStateAbbreviationCd
ZIP105281633ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2025-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN133806788EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE OVARIAN CANCER RESEARCH FUND INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlOVARBusinessNameControlTxt
Phone2122681002PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line145 ROCKEFELLER PLAZA 20TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP101113193ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonAUDRA L MORANPersonNm
Person TitlePRESIDENT & CEOPersonTitleTxt
Phone2122681002PhoneNum
Signature2026-09-11SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonMELISSA MODELSONPreparerPersonNm
PTINP01603524PTIN
Phone9143818900PhoneNum
Preparation2026-09-10PreparationDt
FieldValueIRS element (for citing)
Tax2025TaxYr

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1OVARIAN CANCER RESEARCH ALLIANCEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerAUDRA L MORANPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line145 ROCKEFELLER PLAZA 20TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP101113193ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$25,301,177GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.OCRAHOPE.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1994FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionOVARIAN CANCER RESEARCH ALLIANCE IS COMMITTED TO PREVENTING, DEVELOPING BETTER TREATMENTS FOR AND ULTIMATELY CURING OVARIAN AND RELATED GYNECOLOGIC CANCERS THROUGH INNOVATIVE RESEARCH, RAISING AWARENESS AND ENSURING THE BEST CARE POSSIBLE THROUGH ADVOCACY AND SUPPORT FOR PATIENTS AND FAMILIES.ActivityOrMissionDesc
Voting Members Governing Body18VotingMembersGoverningBodyCnt
Voting Members Independent18VotingMembersIndependentCnt
Total Employee29TotalEmployeeCnt
Total Volunteers1937TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$8,538,194PYContributionsGrantsAmt
CY Contributions Grants$17,855,600CYContributionsGrantsAmt
PY Program Service Revenue$301,023PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$1,219,860PYInvestmentIncomeAmt
CY Investment Income$1,754,552CYInvestmentIncomeAmt
PY Other Revenue-$11,079PYOtherRevenueAmt
CY Other Revenue-$77,316CYOtherRevenueAmt
PY Total Revenue$10,047,998PYTotalRevenueAmt
CY Total Revenue$19,532,836CYTotalRevenueAmt
PY Grants And Similar Paid$6,428,064PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$8,681,352CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$2,887,953PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$3,741,701CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,954,779CYTotalFundraisingExpenseAmt
PY Other Expenses$4,240,499PYOtherExpensesAmt
CY Other Expenses$4,915,016CYOtherExpensesAmt
PY Total Expenses$13,556,516PYTotalExpensesAmt
CY Total Expenses$17,338,069CYTotalExpensesAmt
PY Revenues Less Expenses-$3,508,518PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$2,194,767CYRevenuesLessExpensesAmt
Total Assets BOY$38,070,603TotalAssetsBOYAmt
Total Assets EOY$42,551,929TotalAssetsEOYAmt
Total Liabilities BOY$14,914,782TotalLiabilitiesBOYAmt
Total Liabilities EOY$15,499,304TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$23,155,821NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$27,052,625NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionOVARIAN CANCER RESEARCH ALLIANCE (OCRA) IS COMMITTED TO PREVENTING, DEVELOPING BETTER TREATMENTS FOR AND ULTIMATELY CURING OVARIAN AND RELATED GYNECOLOGIC CANCERS THROUGH INNOVATIVE RESEARCH, RAISING AWARENESS AND ENSURING THE BEST CARE POSSIBLE THROUGH ADVOCACY AND SUPPORT FOR PATIENTS AND FAMILIES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$10,447,492ExpenseAmt
Grant$8,681,352GrantAmt
Revenue$0RevenueAmt
DescOVARIAN CANCER RESEARCH ALLIANCE WAS FOUNDED IN 1994 (AS THE OVARIAN CANCER RESEARCH FUND, INC.) AND IS A FULL-SPECTRUM ORGANIZATION FUNDING MEDICAL RESEARCH, ADVOCATING ON BEHALF OF PATIENTS AND PROVIDING SUPPORT AND RESOURCES TO PATIENTS AND THEIR FAMILIES.OVARIAN CANCER IS THE DEADLIEST OF ALL GYNECOLOGIC CANCERS AND RANKS FIFTH AS THE CAUSE OF CANCER DEATH IN WOMEN. IN 2025, THERE WERE 20,890 NEW CASES OF OVARIAN CANCER AND 12,730 DEATHS FROM THE DISEASE IN THE UNITED STATES. THE ACCOMPLISHMENTS OF OCRA'S PROGRAMS REFLECT OUR COMMITMENT TO THE OVARIAN AND GYNECOLOGIC CANCER COMMUNITIES. SINCE 1998, OCRA HAS AWARDED 457 GRANTS FOR OVARIAN AND RELATED CANCER RESEARCH TO PHYSICIANS AND SCIENTISTS AT 103 LEADING MEDICAL CENTERS, WHICH IS AN INVESTMENT TOTALING OVER $137 MILLION. THANKS TO THE GENEROSITY OF OUR DONORS, OUR INVESTIGATORS ARE WORKING ON MANY FRONTS TO DEFEAT OVARIAN CANCER. BY DEVELOPING INNOVATIVE STRATEGIES FOR EARLY DETECTION AND EXPLORING THE GENETICS THAT INCREASE RISK FOR OVARIAN CANCER, WE HOPE TO SAVE WOMEN'S LIVES BY FINDING THE CANCER EARLY OR STOPPING IT BEFORE IT EVEN STARTS. RESEARCHERS ARE GAINING INSIGHTS INTO THE MANY TYPES OF OVARIAN AND RELATED CANCERS TO DETERMINE THE ORIGINS, WHICH MAY LEAD TO MORE EFFECTIVE TESTING AND EFFECTIVE IMMUNOTHERAPY TREATMENT OPTIONS. FURTHERMORE, THEY ARE IDENTIFYING NEW AND BETTER TREATMENTS TO IMPROVE OVERALL SURVIVAL, PREVENT DRUG RESISTANCE, MINIMIZE SIDE EFFECTS, PREVENTING RECURRENCE AND METASTASIS AND ENHANCE PATIENTS' QUALITY OF LIFE. IN ADDITION TO OCRA'S ESTABLISHED RESEACH GRANT PROGRAM, OCRA ALSO CONTINUED THE HEALTH EQUITY RESEARCH GRANTS BEGUN IN 2023. THESE GRANTS FOCUS ON IMPROVING HEALTH EQUITY IN THE GYNECOLOGIC CANCER SPACE. AS PART OF OUR GLOBAL GYNECOLOGIC CANCER CONSORTIUM, MADE UP OF PARTNERS FROM THE UK, AUSTRALIA AND CANADA, OCRA LAUNCHED A NEW AI GRANT IN 2025. THE FIRST GRANT WAS AWARDED IN 2025 WITH A START DATE OF 2026. AND WITH THE RIVKIN CENTER JOINING OCRA IN 2025, THE FORMER RIVKIN PILOT GRANTS WERE ADDED, AS WELL. ACCOMPLISHMENTS ACHIEVED AS A RESULT OF OCRA GRANTS INCLUDE:IDENTIFIED A MOLECULE THAT COULD BE KEY TO IMPROVING IMMUNE RESPONSE AGAINST OVARIAN CANCER; SOUGHT TO UNDERSTAND WHY CERTAIN OVARIAN CANCER CELLS RESIST OLAPARIB TREATMENT, AND DISCOVERED THAT INTRODUCING A SECOND DRUG (MIFEPRISTONE) WHILE TARGETING CERTAIN CELLS (POLYPLOID GIANT CANCER CELLS) MAY OFFER A SOLUTION; IDENTIFIED A PREVIOUSLY UNKNOWN CHEMORESISTANT PATHWAY IN HGSC WHICH LED TO WORKING ON A NEW THERAPY TO OVERCOME THIS; SHED NEW LIGHT ON HOW THE MOST COMMON SUBTYPE OF OVARIAN CANCER DEVELOPS AND METASTASIZES, BY IDENTIFYING A KEY MOLECULE THAT ALLOWS MALIGNANCIES IN THE FALLOPIAN TUBE TO MIGRATE TO THE OVARIES AND CONTINUE TO GROW; UNCOVERED SEVERAL MECHANISMS OF IMMUNE ESCAPE TO HELP EXPLAIN SOME OVARIAN CANCERS' RESISTANCE TO IMMUNOTHERAPY; SHOWED THAT RUCAPARIB EXTENDS PROGRESSION FREE SURVIVAL IN OVARIAN CANCER; DISCOVERED THAT 18% OF OVARIAN CANCER CASES INVOLVE INHERITED MUTATIONS; PINPOINTED TWO GENES THAT TRIGGER OVARIAN CANCER; DEMONSTRATED HOW GENE THERAPY MAY HELP PATIENTS WITH RECURRENT DISEASE; DISCOVERED THAT ANALYZING DATA FROM PAP SMEARS COULD HELP DETECT ENDOMETRIAL AND OVARIAN CANCER; ESTABLISHED THERE IS NO LINK BETWEEN OBESITY AND RISK FOR THE MOST COMMON TYPE OF OVARIAN CANCER; SHOWN THAT FGFR4 IS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET FOR OVARIAN CANCER; DEFINED SIMILARITIES BETWEEN SOME ENDOMETRIAL, BREAST AND OVARIAN CANCERS; EXPLAINED HOW AN EXPERIMENTAL DRUG MAY BE HELPFUL IN FIGHTING PLATINUM-RESISTANT OVARIAN CANCER; IDENTIFIED BIOMARKERS THAT CAN BE USED TO MONITOR THE DEVELOPMENT OF PLATINUM RESISTANCE THERAPIES; IDENTIFIED NOVEL BIOMARKERS OF HGSOC AND SPECIFIC DRUG TARGETS; TARGETED MDM2 DEGRADATION AS A NOVEL TREATMENT FOR OVARIAN CANCER; USED MACHINE LEARNING TO BRIDGE THE GAP BETWEEN DISPARATE DATA SETS SPECIFICALLY IN PATIENTS WITH HGSOC; DOSED THE FIRST PATIENTS IN THE CLINICAL TRIAL "IMMUNOTHERAPY PLATFORM STUDY IN PLATINUM RESISTANT HIGH GRADE SEROUS OVARIAN CANCER (IPROC)" (NCT04918186); FOUND KEY PROTEINS IN HGSOC CANCER CELLS WHICH RESULTED IN COMBINED TREATMENT OPTIONS WHICH RESULTED IN SMALLER TUMORS AND LONGER SURVIVAL; SHOWED HOW SURGICAL REMOVAL OF FALLOPIAN TUBES MAY REDUCE OVARIAN CANCER RISK; UNCOVERED SEVERAL MECHANISMS OF IMMUNE ESCAPE TO HELP EXPLAIN SOME OVARIAN CANCERS' RESISTANCE TO IMMUNOTHERAPY; FOUND A DECREASE IN OVARIAN CARCINOMA INCIDENCE AFTER SALPINGECTOMY FOR TREATING ECTOPIC PREGNANCY; SHOWED PARP1 IS INVOLVED IN REPAIR OF TELOMERES, AND THAT IMPAIRING THIS PROCESS CAN LEAD TO TELOMERE SHORTENING AND GENOMIC INSTABILITY THAT CAN CAUSE CANCER; DEVELOPED A PROOF-OF-CONCEPT STUDY TO SHOW HOW THREE-DIMENSIONAL MODELING CAN SHOW HOW CANCER CELLS AND CAR-T INTERACT WHICH WILL HOPEFULLY LEAD TO BETTER TREATMENTS IN PATIENTS WITH HGSOC SOLID TUMORS; DISCOVERED THAT AGGRESSIVE OVARIAN CANCERS OFTEN SHOW SUDDEN LARGE-SCALE DNA DAMAGE, POINTING TO DISTINCT ORIGINS AND DETECTION STRATEGIES; AND IDENTIFIED THAT LOSS OF A GENE CALLED SMARCA4 MAKES OVARIAN CANCER CELLS MORE VISIBLE TO THE IMMUNE SYSTEM, BOOSTING IMMUNE ATTACK AND SUGGESTING A NEW STRATEGY TO IMPROVE IMMUNOTHERAPY.IN 2025 ALONE, OCRA RESEARCHERS: DEVELOPED A PIONEERING AI TOOL TO BETTER PREDICT TREATMENT RESPONSE, A STEP TOWARD EARLIER PERSONALIZED TREATMENT PLANS; SYSTEMATICALLY TESTED EXISTING THERAPIES TO FIND AN EFFECTIVE DRUG COMBINATION THAT SHOWS PROMISE; UNCOVERED KEY DIFFERENCES IN IMMUNE ENVIRONMENTS BETWEEN PRIMARY TUMORS AND METASTASES THAT MAY EXPLAIN WHY HIGH-GRADE SEROUS OVARIAN CARCINOMA OFTEN SUPPRESSES THE IMMUNE SYSTEM; FOUND THAT MUCINOUS OVARIAN CANCERS WITH KEY GENE CHANGES WERE ASSOCIATED WITH WORSE SURVIVAL EVEN AT EARLY STAGES, SUGGESTING GENETIC TESTING AT DIAGNOSIS MAY HELP GUIDE CARE AND PREDICT OUTCOMES; DISCOVERED THAT BLOCKING A KEY NUTRIENT WHILE ALSO USING IMMUNOTHERAPY COULD OFFER A PROMISING NEW TREATMENT STRATEGY FOR AROUND HALF OF OVARIAN CLEAR CELL CANCERS; FOUND THAT AMONG PEOPLE DIAGNOSED WITH AN EARLY OVARIAN CANCER PRECURSOR, OLDER PATIENTS AND BLACK PATIENTS FACE WORSE SURVIVAL, UNDERSCORING THE URGENT NEED FOR MORE TAILORED CARE AND TREATMENT STRATEGIES; FOUND THAT PROBIOTIC SUPPLEMENTS MAY HELP GYNECOLOGIC CANCER PATIENTS REDUCE RADIATION-RELATED GUT SIDE EFFECTS; FOUND THAT A SPECIFIC DNA-REPAIR PROTEIN HELPS CANCER CELLS GROW BY SWITCHING ON A GROWTH PATHWAY, HINTING AT A POTENTIAL TREATMENT TARGET TO MAKE TUMORS MORE TREATABLE WHILE SPARING HEALTHY CELLS; FOUND THAT ENGINEERED IMMUNE CELLS WORKED MUCH BETTER IN COMBINATION WITH THREE IMMUNOTHERAPIES, ALLOWING THE IMMUNE CELLS TO STAY ACTIVE LONGER AND KILL OVARIAN CANCER IN MICE MORE EFFECTIVELY; SHOWED THAT OVARIAN CANCER RECURRENCE IS DRIVEN BY A SMALL NUMBER OF PRE-EXISTING, TREATMENT-RESISTANT CANCER CELL CLONES WHICH ARE DETECTABLE THROUGH A NEW BLOOD TEST THAT MAY PAVE THE WAY TO PREVENTING RECURRENCE; FOUND THAT SPECIALLY ENGINEERED T CELLS THAT SECRETE "BITE" MOLECULES, WHEN COMBINED WITH OTHER IMMUNOTHERAPIES, CAN TRIGGER STRONG AND LASTING ANTI-TUMOR IMMUNE RESPONSES AGAINST OVARIAN CANCER IN MICE; FOUND A WAY TO REPROGRAM MACROPHAGES TO MAKE THE IMMUNE SYSTEM FIGHT THE CANCER AGAIN; DISCOVERED A WAY TO SELECTIVELY REMOVE CERTAIN "PRO-CANCER" IMMUNE CELLS IN OVARIAN TUMORS BY TARGETING A SPECIFIC POCKET ON THE RETINOBLASTOMA (RB) PROTEIN, WHICH HELPS THE IMMUNE SYSTEM FIGHT THE CANCER MORE EFFECTIVELY; CREATED THE FIRST STANDARDIZED SET OF GUIDELINES, TOOLS, AND REFERENCE DATASETS FOR SPATIAL TRANSCRIPTOMICS EXPERIMENTS TO HELP SCIENTISTS COMPARE RESULTS ACROSS LABS AND MEASURE THE QUALITY AND RELIABILITY; UNCOVERED THE RULES THAT GUIDE IMMUNE CELL SIGNALING AND USED THIS KNOWLEDGE TO PROVIDE A WEB RESOURCE TO FACILITATE PROTEIN DESIGN EFFORTS, WHICH CAN BE USED TO DEVELOP NEW IMMUNE-BASED THERAPIES.EVERY DOLLAR DONATED BRINGS US CLOSER TO A CURE FOR THIS DEVASTATING DISEASE. FOR MORE INFORMATION OR TO JOIN US IN OUR FIGHT, PLEASE VISIT OCRA'S WEBSITE AT WWW.OCRAHOPE.ORG.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$3,162,885ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescIN 2025, OVARIAN CANCER RESEARCH ALLIANCE (OCRA) PROVIDED COMPREHENSIVE EDUCATION, SUPPORT, AND NAVIGATION SERVICES TO THOUSANDS OF INDIVIDUALS AFFECTED BY OVARIAN AND GYNECOLOGIC CANCERS. OCRA'S PATIENT SUPPORT TEAM RESPONDED TO 4,237 PATIENT AND CAREGIVER CONTACTS THROUGH OUR PATIENT SUPPORT LINE, A 68% INCREASE FROM 2024, PROVIDING EMOTIONAL SUPPORT, INFORMATION, CLINICAL TRIAL GUIDANCE, PEER MENTORING, AND CARE NAVIGATION. OCRA'S WOMAN TO WOMAN PEER MENTOR PROGRAM CONTINUED TO CONNECT NEWLY DIAGNOSED PATIENTS WITH TRAINED SURVIVOR MENTORS THROUGH 19 ACTIVE SITES NATIONWIDE AND A NATIONAL VIRTUAL MATCHING PROGRAM. SINCE ITS LAUNCH, THE PROGRAM HAS FACILITATED MORE THAN 2,800 MENTOR MATCHES. IN 2025, THE NATIONAL TEAM COMPLETED 103 MATCHES AND SUPPORTED 167 MENTORS. OCRA ALSO PROVIDED INDIVIDUALIZED COUNSELING THROUGH ITS STEPS 1:1 COUNSELING PROGRAM AND FACILITATED ONGOING SUPPORT THROUGH STAYING CONNECTED, WHICH ENGAGED 3,530 PARTICIPANTS IN VIRTUAL SUPPORT AND EXPRESSIVE ARTS PROGRAM DURING THE YEAR. TO ADDRESS THE EDUCATIONAL NEEDS OF PATIENTS AND CAREGIVERS, OCRA DELIVERED ITS INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE, WEBINARS, WORKSHOPS, ROUNDTABLES, AND MONTHLY EDUCATIONAL PROGRAMS FOCUSED ON DIAGNOSIS, TREATMENT ADVANCES, SURVIVORSHIP, BIOMARKER TESTING, AND CLINICAL TRIALS. OFFERED FREE OF CHARGE FOR THE FIRST TIME, OCRA'S INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE EXPANDED ITS REACH TO MORE THAN 2,100 PARTICIPANTS WORLDWIDE. NEARLY 300 INDIVIDUALS PARTICIPATED IN OCRA'S EDUCATIONAL WORKSHOPS, INCLUDING OVARIAN CANCER 101, ENDOMETRIAL/UTERINE CANCER 101, AND SURVIVORSHIP SERIES, WHILE NATIONAL WEBINARS REACHED ALMOST 900 PARTICIPANTS. OCRA'S NEW STAYING CURRENT EDUCATIONAL SERIES PROVIDED DISEASE-SPECIFIC UPDATES AND CLINICAL TRIAL INFORMATION TO MORE THAN 200 PARTICIPANTS. COLLECTIVELY, OCRA'S EDUCATIONAL PROGRAMS REACHED MORE THAN 4,000 PARTICIPANTS IN 2025, PROVIDING TIMELY, EVIDENCE-BASED INFORMATION TO HELP PATIENTS AND CAREGIVERS MAKE INFORMED DECISIONS THROUGHOUT THEIR CANCER JOURNEY.IN ADDITION TO ITS SUPPORT AND EDUCATION PROGRAMS, OCRA OFFERS FREE GENETIC TESTING TO QUALIFIED HIGH-RISK INDIVIDUALS AND FACILITATES ACCESSS TO CERTIFIED GENETIC COUNSELORS. SINCE THE PROGRAM'S INCEPTION, OCRA HAS HELPED MORE THAN 3,000 INDIVIDUALS BETTER UNDERSTAND THEIR INHERITED RISK FOR OVARIAN AND OTHER GYNECOLOGIC CANCERS, EMPOWERING THEM AND THEIR FAMILIES TO MAKE INFORMED HEALTHCARE DECISIONS. ADDITIONALLY, OCRA'S CLINICAL TRIAL NAVIGATOR CONTINUED TO EXPAND ACCESS TO CLINICAL TRIAL INFORMATION, WITH 1,540 COMPLETED QUESTIONNAIRES AND MORE THAN 11,700 WEBSITE VISITS IN 2025.OCRA IS ALSO COMMITTED TO DEVELOPING THE NEXT GENERATION OF HEALTHCARE PROFESSIONALS DEDICATED TO IMPROVING OUTCOMES FOR INDIVIDUALS DIAGNOSED WITH GYNECOLOGIC CANCERS. THROUGH OCRA'S ONCOLOGY SOCIAL WORK FIELD PLACEMENT PROGRAM, MASTER OF SOCIAL WORK CANDIDATES RECEIVE SPECIALIZED TRAINING AND SUPERVISION FROM LICENSED CLINICAL SOCIAL WORKERS, GAINING EXPERIENCE ADDRESSING THE UNIQUE PSYCHOLOGICAL, EMOTIONAL, AND PRACTICAL NEEDS OF PATIENTS AND CAREGIVERS AFFECTED BY GYNECOLOGIC CANCERS.OCRA'S SURVIVORS TEACHING STUDENTS (STS) PROGRAM TRAINS OVARIAN CANCER SURVIVORS AND CAREGIVERS TO CONDUCT PRESENTATIONS IN MEDICAL EDUCATION PROGRAMS TO EDUCATE FUTURE HEALTHCARE PROVIDERS ABOUT OVARIAN CANCER. SURVIVORS SHARE THEIR STORIES OF DIAGNOSIS, TREATMENT AND BEYOND, ALONG WITH FACTS ABOUT THE DISEASE. IN 2025, MORE THAN 930 SURVIVOR VOLUNTEERS DELIVERED MORE THAN 400 PRESENTATIONS IN THE US, UK, AND AUSTRALIA REACHING OVER 10,627 MEDICAL, NURSING, AND PHYSICIAN'S ASSISTANT STUDENTS. THESE PRESENTATIONS ENSURE THE NEXT GENERATION OF HEALTH CARE PROVIDERS UNDERSTAND BASIC FACTS ABOUT THE DISEASE, ARE AWARE OF RISK FACTORS, AND CAN IDENTIFY THE SIGNS AND SYMPTOMS OF OVARIAN CANCER, HELPING ENSURE A TIMELY DIAGNOSIS.THROUGH THESE PROGRAMS, OCRA EMPOWERS PATIENTS AND CAREGIVERS WITH TRUSTED INFORMATION, EMOTIONAL SUPPORT, AND CONNECTIONS TO RESOURCES THAT IMPROVE QUALITY OF LIFE AND INFORMED DECISION-MAKING FROM DIAGNOSIS THROUGH SURVIVORSHIP AND BEYOND.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$595,806ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescOVARIAN CANCER RESEARCH ALLIANCE IS A POWERFUL VOICE ON CAPITOL HILL, IN STATEHOUSES AROUND THE COUNTRY AND WITH FEDERAL AGENCIES FOR EVERYONE TOUCHED BY GYNECOLOGIC CANCER. IN 2025, OCRA ESTABLISHED ITS CENTER FOR PUBLIC POLICY TO EXPAND POLICY EDUCATION, LEGISLATIVE TRACKING, AND ADVOCACY ENGAGEMENT OPPORTUNITIES FOR PATIENTS, CAREGIVERS, AND SUPPORTERS NATIONWIDE. OCRA TRAINED AND MOBILIZED MORE THAN 160 ADVOCATES AND SUPPORTERS TO ENGAGE IN THE POLICYMAKING PROCESS. NEARLY 120 ADVOCATES FROM 35 STATES AND THE DISTRICT OF COLUMBIA PARTICIPATED IN OCRA'S ADVOCACY DAY, CONDUCTING MORE THAN 135 MEETINGS WITH CONGRESSIONAL OFFICES. THROUGH 12 GRASSROOTS ACTION ALERTS, ADVOCATES GENERATED MORE THAN 21,000 MESSAGES TO POLICYMAKERS, AND MORE THAN 6,000 NEW ADVOCATES JOINED OCRA'S ADVOCACY NETWORK. OCRA'S ADVOCACY CONTRIBUTED TO PRESERVING FEDERAL FUNDING FOR OVARIAN CANCER RESEARCH AND EDUCATION PROGRAMS, SUPPORTED ENACTMENT OF STATE BIOMARKER ACCESS LAWS, SECURED BIPARTISAN CONGRESSIONAL SUPPORT FOR INCREASED OVARIAN CANCER RESEARCH FUNDING, AND HELPED OBTAIN MORE THAN 120 PROCLAMATIONS AND RESOLUTIONS RECOGNIZING OVARIAN CANCER AWARENESS MONTH.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$14,206,183TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl EntYes (1)RelatedOrganizationCtrlEntInd
Transaction With Control Ent0TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document80IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee29EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members18GoverningBodyVotingMembersCnt
Independent Voting Member18IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1AUDRA L MORANBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone2122681002PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line145 ROCKEFELLER PLAZA 20TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP101113193ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (30 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
JOHN ORRICO
CHAIR3.000.00Yes (X)Yes (X)$0$0$0
MATTHEW NEAL MILLER
VICE PRESIDENT2.000.00Yes (X)Yes (X)$0$0$0
MARK TESSAR
TREASURER2.000.00Yes (X)Yes (X)$0$0$0
ROBIN S COHEN
SECRETARY2.000.10Yes (X)Yes (X)$0$0$0
DEBRA BIRNBAUM
DIRECTOR1.000.00Yes (X)$0$0$0
JEANNETTE CHANG
DIRECTOR1.000.00Yes (X)$0$0$0
CARMEL J COHEN MD
DIRECTOR THRU AUG 20251.000.00Yes (X)$0$0$0
ANDREW FEUERSTEIN ESQ
DIRECTOR1.000.00Yes (X)$0$0$0
CAROL J HAMILTON
DIRECTOR1.000.00Yes (X)$0$0$0
JOHN W HANSBURY ESQ
DIRECTOR1.000.10Yes (X)$0$0$0
CAROLINE HIRSCH
DIRECTOR1.000.00Yes (X)$0$0$0
VERONICA JORDAN
DIRECTOR THRU SEPT 20251.000.00Yes (X)$0$0$0
THOMAS C LIEBMAN
DIRECTOR1.000.00Yes (X)$0$0$0
DANA L MARK ESQ
DIRECTOR1.000.00Yes (X)$0$0$0
CHRIS NEWCOMB
DIRECTOR THRU DEC 20251.000.00Yes (X)$0$0$0
MELISSA RIVKIN
DIRECTOR1.000.00Yes (X)$0$0$0
LISA SCHREIBER
DIRECTOR1.000.00Yes (X)$0$0$0
LAURA SHAWVER
DIRECTOR1.000.00Yes (X)$0$0$0
MEI-LI DA SILVA VINT ESQ
DIRECTOR1.000.00Yes (X)$0$0$0
ELLE SIMONE SCOTT
DIRECTOR1.000.00Yes (X)$0$0$0
CHRISTOPHER TILBERIS
DIRECTOR1.000.00Yes (X)$0$0$0
AUDRA L MORAN
PRESIDENT & CEO40.000.10Yes (X)$333,548$0$35,207
JONATHAN ZEIDMAN
CHIEF DEVELOPMENT OFFICER40.000.00$201,949$0$43,479Yes (X)
SARAH C DEFEO
CHIEF PROGRAM OFFICER40.000.00$171,149$0$69,876Yes (X)
TRACY MOORE
VICE PRESIDENT, SUPPORT & EDUCATION40.000.00$162,573$0$28,215Yes (X)
ANNE METTE HERTZ SR DIR
TREATMENT ACCESS & SCIENTIFIC EDUCATION40.000.00$145,000$0$4,085Yes (X)
CHAD RAMSEY
VICE PRESIDENT, POLICY40.000.00$126,974$0$26,691Yes (X)
JESSICA HUGHSON ANDRADE
SENIOR DIRECTOR, STRATEGIC ALLIANCE40.000.00$111,935$0$24,237Yes (X)
NICOLE WARGO
VP - PHILANTHROPIC PARTNER40.000.00$109,257$0$64,705Yes (X)
BIBI ALI
FORMER CHIEF FINANCIAL OFFICER0.000.00$157,000$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,519,385TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$296,495TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K13IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (1)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
CIRRO BIO INC
225 SOUTH KING STREET SUITE 800SEATTLEWA98104DATA SUPPORT SERVICES$450,000
COSGROVE ACCOUNTING
11161 EAST STATE ROAD 70 SUITE 110LAKEWOOD RANCHFL34202ACCOUNTING SERVICES$233,127
COLOR HEALTH
831 MITTEN ROAD SUITE 100BURLINGAMECA94010HEREDITARY TESTING$225,489
ADC STRATEGIC COMMUNICATIONS
14 KNOB HILLPUTNAM VALLEYNY10579MARKETING & COMMUNICATION SERVICES$220,766
AMPLIFI
600 RYERSON ROAD SUITE GLINCOLN PARKNJ07035MAILING SERVICES$190,045
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K9CntrctRcvdGreaterThan100KCnt
Fundraising$458,850FundraisingAmt
All Other Contributions$17,396,750AllOtherContributionsAmt
Noncash Contributions$1,141,580NoncashContributionsAmt
Total Contributions$17,855,600TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,068,907TotalRevenueColumnAmt
Exclusion$1,068,907ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$6,341,544SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$5,655,899SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$685,645SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$685,645TotalRevenueColumnAmt
Exclusion$685,645ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$458,850ContriRptFundraisingEventAmt
Fundraising Direct Expenses$112,442FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$112,442TotalRevenueColumnAmt
Exclusion-$112,442ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmt
INSURANCE PROCEEDS900099$35,000$35,000
OTHER INCOME900099$126$126
FieldValueIRS element (for citing)
Other Revenue Total$35,126OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$19,532,836TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$1,677,236ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$7,888,202TotalAmt
Program Services$7,888,202ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$793,150TotalAmt
Program Services$793,150ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$855,208TotalAmt
Program Services$532,680ProgramServicesAmt
Management And General$61,843ManagementAndGeneralAmt
Fundraising$260,685FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$157,000TotalAmt
Management And General$157,000ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$2,067,817TotalAmt
Program Services$1,418,885ProgramServicesAmt
Management And General$64,833ManagementAndGeneralAmt
Fundraising$584,099FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$54,256TotalAmt
Program Services$29,791ProgramServicesAmt
Management And General$5,657ManagementAndGeneralAmt
Fundraising$18,808FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$391,462TotalAmt
Program Services$249,689ProgramServicesAmt
Management And General$38,245ManagementAndGeneralAmt
Fundraising$103,528FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$215,958TotalAmt
Program Services$136,655ProgramServicesAmt
Management And General$20,065ManagementAndGeneralAmt
Fundraising$59,238FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$124,939TotalAmt
Program Services$42,766ProgramServicesAmt
Management And General$76,648ManagementAndGeneralAmt
Fundraising$5,525FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$304,507TotalAmt
Management And General$304,507ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$9,000TotalAmt
Program Services$9,000ProgramServicesAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$87,365TotalAmt
Management And General$87,365ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,501,720TotalAmt
Program Services$1,207,117ProgramServicesAmt
Management And General$213,272ManagementAndGeneralAmt
Fundraising$81,331FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$476,124TotalAmt
Program Services$396,611ProgramServicesAmt
Management And General$1,441ManagementAndGeneralAmt
Fundraising$78,072FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$805,711TotalAmt
Program Services$297,041ProgramServicesAmt
Management And General$81,578ManagementAndGeneralAmt
Fundraising$427,092FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$895,459TotalAmt
Program Services$605,873ProgramServicesAmt
Management And General$44,594ManagementAndGeneralAmt
Fundraising$244,992FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$68,238TotalAmt
Program Services$43,180ProgramServicesAmt
Management And General$6,340ManagementAndGeneralAmt
Fundraising$18,718FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$183,739TotalAmt
Program Services$167,510ProgramServicesAmt
Management And General$1,433ManagementAndGeneralAmt
Fundraising$14,796FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$150,636TotalAmt
Program Services$113,394ProgramServicesAmt
Management And General$691ManagementAndGeneralAmt
Fundraising$36,551FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$30,000TotalAmt
Program Services$18,984ProgramServicesAmt
Management And General$2,787ManagementAndGeneralAmt
Fundraising$8,229FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$41,968TotalAmt
Program Services$26,557ProgramServicesAmt
Management And General$3,899ManagementAndGeneralAmt
Fundraising$11,512FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
GENETIC TESTING$225,489$225,489
REPAIRS AND MAINTENANCE$4,366$4,366
EMPLOYEE EVENTS AND REC$4,296$2,693$1,603
OTHER OPERATING EXPENSE$1,459$916$543

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$17,338,069TotalAmt
Program Services$14,206,183ProgramServicesAmt
Management And General$1,177,107ManagementAndGeneralAmt
Fundraising$1,954,779FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$2,107,359BOYAmt
EOY$2,710,809EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,049,345BOYAmt
EOY$2,711,451EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$1,212,071BOYAmt
EOY$434,380EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$69,269BOYAmt
EOY$149,863EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$313,290LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$263,290LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$80,000BOYAmt
EOY$50,000EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$33,033,627BOYAmt
EOY$36,071,656EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$518,932BOYAmt
EOY$423,770EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$38,070,603BOYAmt
EOY$42,551,929EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$361,274BOYAmt
EOY$264,987EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$14,132,020BOYAmt
EOY$14,759,507EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$100,000EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$421,488BOYAmt
EOY$374,810EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$14,914,782BOYAmt
EOY$15,499,304EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$10,207,440BOYAmt
EOY$10,569,811EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$12,948,381BOYAmt
EOY$16,482,814EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$23,155,821BOYAmt
EOY$27,052,625EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$38,070,603BOYAmt
EOY$42,551,929EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$2,194,767ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$1,439,645NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$262,392OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$11,263,534CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$15,386,443CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$11,556,311CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,538,194CurrentTaxYearMinus1YearAmt
Current Tax Year$17,855,600CurrentTaxYearAmt
Total$64,600,082TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$11,263,534CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$15,386,443CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$11,556,311CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,538,194CurrentTaxYearMinus1YearAmt
Current Tax Year$17,855,600CurrentTaxYearAmt
Total$64,600,082TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$11,342,652SubstantialContributorsTotAmt
Public Support Total170$53,257,430PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$542,131CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$710,226CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,095,100CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$992,906CurrentTaxYearMinus1YearAmt
Current Tax Year$1,068,907CurrentTaxYearAmt
Total$4,409,270TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year$35,126CurrentTaxYearAmt
Total$35,126TotalAmt
FieldValueIRS element (for citing)
Total Support$69,044,478TotalSupportAmt
Gross Receipts Rltd Activities$1,334,959GrossReceiptsRltdActivitiesAmt
Public Support CY1700.77130PublicSupportCY170Pct
Public Support PY1700.75530PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$5,498FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$11,461FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$16,959FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$15,278,966FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$15,295,925FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$914,796FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$228,699FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$723,133CurrentYearMinus3Amt
Current Year Minus2$837,638CurrentYearMinus2Amt
Current Year Minus1$751,838CurrentYearMinus1Amt
Current Year$914,796CurrentYearAmt
Total$3,227,405TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$4,841,108LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$0CurrentYearMinus3Amt
Current Year Minus2$0CurrentYearMinus2Amt
Current Year Minus1$22,395CurrentYearMinus1Amt
Current Year$16,959CurrentYearAmt
Total$39,354TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$180,783CurrentYearMinus3Amt
Current Year Minus2$209,410CurrentYearMinus2Amt
Current Year Minus1$187,960CurrentYearMinus1Amt
Current Year$228,699CurrentYearAmt
Total$806,852TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,210,278GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$0CurrentYearMinus3Amt
Current Year Minus2$0CurrentYearMinus2Amt
Current Year Minus1$7,500CurrentYearMinus1Amt
Current Year$5,498CurrentYearAmt
Total$12,998TotalAmt

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$115,471OtherCostOrOtherBasisAmt
Depreciation$115,471DepreciationAmt
Book Value$0BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$197,819OtherCostOrOtherBasisAmt
Depreciation$147,819DepreciationAmt
Book Value$50,000BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$50,000TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescLEASE LIABILITYDesc
Amt$374,810Amt
FieldValueIRS element (for citing)
Total Liability$374,810TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$21,581,159TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$1,439,645NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$583,601DonatedServicesAndUseFcltsAmt
Other Revenue$112,442OtherRevenueAmt
Revenue Not Reported$2,135,688RevenueNotReportedAmt
Revenue Subtotal$19,445,471RevenueSubtotalAmt
Investment Expenses Not Incld$87,365InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$87,365RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$19,532,836TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$17,684,355TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$583,601DonatedServicesUseFcltsAmt
Other Expenses Included$112,442OtherExpensesIncludedAmt
Expenses Not Reported$696,043ExpensesNotReportedAmt
Expenses Subtotal$16,988,312ExpensesSubtotalAmt
Investment Expenses Not Incld2$87,365InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$262,392OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$349,757ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$17,338,069TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART X, LINE 2:OCRA RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT OCRA HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. OCRA IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR YEARS PRIOR TO DECEMBER 31, 2022.
PART XI, LINE 2D - OTHER ADJUSTMENTS:FUNDRAISING EVENT EXPENSES REPORTED ON PART VIII 112,442.
PART XII, LINE 2D - OTHER ADJUSTMENTS:FUNDRAISING EVENT EXPENSES REPORTED ON PART VIII 112,442.
PART XII, LINE 4B - OTHER ADJUSTMENTS:GRANT REFUNDS 262,392.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp

FieldValueIRS element (for citing)
RegionNORTH AMERICARegionTxt
Offices0OfficesCnt
Employee0EmployeeCnt
Type Of Activities ConductedGRANTMAKINGTypeOfActivitiesConductedTxt
Region Total Expenditures$793,150RegionTotalExpendituresAmt
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$793,150SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$793,150TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp

FieldValueIRS element (for citing)
RegionNORTH AMERICARegionTxt
Purpose Of GrantRESEARCHPurposeOfGrantTxt
Cash Grant$793,150CashGrantAmt
Manner Of Cash DisbursementWIREMannerOfCashDisbursementTxt
Non Cash Assistance$0NonCashAssistanceAmt
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:OCRA MONITORS THE USE OF GRANT FUNDS BY REQUIRING ALL GRANTEES TO SUBMIT YEARLY FINANCIAL AND NARRATIVE PROGRESS REPORTS DETAILING THE USE OF FUNDS AND PROGRAM OUTCOMES. THESE REPORTS ARE REVIEWED BY OCRA TO CONFIRM COMPLIANCE WITH THE STATED CHARITABLE OBJECTIVES.
PART I, LINE 3:THE ORGANIZATION USED THE ACCRUAL METHOD OF ACCOUNTING TO ACCOUNT FOR EXPENDITURES.

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1SUMMERUNEvent1Nm
Gross Receipts Event1$332,429GrossReceiptsEvent1Amt
Charitable Contri Event1$332,429CharitableContriEvent1Amt
Other Direct Expenses Event1$100,874OtherDirectExpensesEvent1Amt
Event2OVARIAN CYCLE & FITNESSEvent2Nm
Gross Receipts Event2$126,421GrossReceiptsEvent2Amt
Charitable Contri Event2$126,421CharitableContriEvent2Amt
Other Direct Expenses Event2$11,568OtherDirectExpensesEvent2Amt
Gross Receipts Total$458,850GrossReceiptsTotalAmt
Charitable Contributions Tot$458,850CharitableContributionsTotAmt
Oth Direct Expnss Total Events$112,442OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$112,442DirectExpenseSummaryEventsAmt
Net Income Summary-$112,442NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (18 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
ONE GUSTAVE L LEVY PLACENEW YORKNY10029136171197501(C)(3)$1,948,941$0RESEARCH
THE UNIVERSITY OF NEW MEXICO
1700 LOMAS BOULEVARD NORTHEASTALBUQUERQUENM87106856000642STATE OF NM$900,000$0RESEARCH
CORNELL UNIVERSITY
WILLARD STRAIGHT HALL MAILBOX 86ITHACANY14853150532082501(C)(3)$900,000$0RESEARCH
ROSELL PARK CANCER INSTITUTE
ELM AND CARLTON STREETSBUFFALONY14263161391608501(C)(3)$899,997$0RESEARCH
MEMORIAL SLOAN KETTERING CANCER CENTER
1275 YORK AVENUENEW YORKNY10065131924236501(C)(3)$650,000$0RESEARCH
MASSACHUSETTS GENERAL HOSPITAL
399 REVOLUTION DRIVE NO 645SOMERVILLEMA02145042697983501(C)(3)$450,000$0RESEARCH
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
10901 NORTH TORREY PINES ROADLA JOLLACA92037510197108501(C)(3)$450,000$0RESEARCH
WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BOULEVARDWINSTONSALEMNC27157223849199501(C)(3)$450,000$0RESEARCH
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE CB1270CHAPEL HILLNC27599566001393STATE OF NC$271,901$0RESEARCH
EMORY UNIVERSITY
1599 CLIFTON ROAD THIRD FLOOR 3101ATLANTAGA30322580566256501(C)(3)$194,950$0RESEARCH
DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE BP418BOSTONMA02215042263040501(C)(3)$100,000$0RESEARCH
FRED HUTCHINSON CANCER CENTER
1100 FAIRVIEW AVENUE NORTHSEATTLEWA98109911935159501(C)(3)$100,000$0RESEARCH
THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
3601 SPRUCE STRETPHILADELPHIAPA19104236434390501(C)(3)$100,000$0RESEARCH
UNIVERSITY OF CALIFORNIA IRVINE
228 ALDRICH HALLIRVINECA92697952226406STATE OF CA$100,000$0RESEARCH
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
1855 FOLSOM STREET SUITE 425SAN FRANCISCOCA94103946036493STATE OF CA$100,000$0RESEARCH
UNIVERSITY OF WASHINGTON
7425 FORSYTH BOULEVARDSAINT LOUISMO63105430653611501(C)(3)$100,000$0RESEARCHMSC1299-414-355
MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION
204 CRAFT AVENUEPITTSBURGHPA15213251462312501(C)(3)$97,413$0RESEARCH
STANFORD UNIVERSITY
485 BROADWAY MAIL CODE 8838REDWOOD CITYCA94063941156365501(C)(3)$75,000$0RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org18Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationOCRA MONITORS THE USE OF GRANT FUNDS BY REQUIRING ALL GRANTEES TO SUBMIT YEARLY FINANCIAL AND NARRATIVE PROGRESS REPORTS DETAILING THE USE OF FUNDS AND PROGRAM OUTCOMES. THESE REPORTS ARE REVIEWED BY OCRA TO CONFIRM COMPLIANCE WITH THE STATED CHARITABLE OBJECTIVES.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (1)SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
AUDRA L MORAN
PRESIDENT & CEO$333,548$0$0$0$0$0$13,342$0$21,865$0$368,755$0$0$0
JONATHAN ZEIDMAN
CHIEF DEVELOPMENT OFFICER$201,949$0$0$0$0$0$0$0$43,479$0$245,428$0$0$0
SARAH C DEFEO
CHIEF PROGRAM OFFICER$171,149$0$0$0$0$0$7,839$0$62,037$0$241,025$0$0$0
TRACY MOORE
VICE PRESIDENT, SUPPORT & EDUCATION$162,573$0$0$0$0$0$6,503$0$21,712$0$190,788$0$0$0
NICOLE WARGO
VP - PHILANTHROPIC PARTNER$109,257$0$0$0$0$0$5,938$0$58,767$0$173,962$0$0$0
BIBI ALI
FORMER CHIEF FINANCIAL OFFICER$0$0$0$0$157,000$0$0$0$0$0$157,000$0$0$0
CHAD RAMSEY
VICE PRESIDENT, POLICY$126,974$0$0$0$0$0$5,079$0$21,612$0$153,665$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 4AFormAndLineReferenceDesc
ExplanationOCRA MADE PAYMENTS TO THE FORMER CHIEF FINANCIAL OFFICER IN THE AMOUNT OF $157,000 IN 2025. THE AMOUNTS WERE TREATED AS TAXABLE COMPENSATION TO THE RECIPIENT AND REPORTED IN PART II, COLUMN (B)(III).ExplanationTxt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution21ContributionCnt
Noncash Contributions Rpt F990$1,141,580NoncashContributionsRptF990Amt
Method Of Determining RevenuesSALES PRICEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, COLUMN (B):FormAndLineReferenceDesc
ExplanationTHE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTORS IN PART I, COLUMN (B) OF SCHEDULE M.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, ITEM CDBA: OVARIAN CANCER RESEARCH ALLIANCE DBA: THE EDMEE FIRTH FUND FOR RESEARCH ON OVARIAN CANCER DBA: THE EDMEE FIRTH FUND FOR RESEARCH IN OVARIAN CANCER
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 IS PROVIDED TO THE BOARD OF DIRECTORS, AUDIT COMMITTEE, TREASURER, AND THE CEO, AND IS REVIEWED WITH THE EXTERNAL CPA PRIOR TO ITS FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12COCRA'S CONFLICT OF INTEREST POLICY (THE "POLICY") APPLIES TO DIRECTORS, OFFICERS AND OTHER EMPLOYEES OR OTHER PERSONS IN A POSITION TO INFLUENCE POLICY OR EXPENDITURES ("KEY PERSONS") WHO ARE ANNUALLY PROVIDED A COPY OF THE POLICY. THE POLICY INCLUDES A REPORTING FORM FOR EXISTING OR POTENTIAL CONFLICTS, AND EACH KEY PERSON IS REQUIRED TO COMPLETE ANNUALLY THE REPORTING FORM. IN CONNECTION WITH ANY PROPOSED TRANSACTION OR ARRANGEMENT BETWEEN OCRA AND ANY SUCH KEY PERSON OR RELATED PERSONS OR ENTITIES THAT RAISES AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST, THE KEY PERSON MUST DISCLOSE THE EXISTENCE AND NATURE OF HIS OR HER RELATIONSHIP AND FINANCIAL INTEREST TO THE PRESIDENT OR THE CHAIR OR CO-CHAIR OF THE BOARD OF DIRECTORS OR THE CHAIR OF ANY AUTHORIZED COMMITTEE. THE POLICY PROVIDES FOR CONSIDERATION OF ANY SUCH TRANSACTION OR ARRANGEMENT BY BOARD OR COMMITTEE MEMBERS BY FOLLOWING CERTAIN MEETING, DISCUSSION, VOTING AND DOCUMENTATION PROCEDURES. OTHER THAN TO PROVIDE INFORMATION OR RESPOND TO QUESTIONS, THE KEY PERSON IS EXCLUDED FROM THE DISCUSSION AND THE DECISION OF WHETHER A CONFLICT OF INTEREST EXISTS.
FORM 990, PART VI, SECTION B, LINE 15OCRA HAS A COMPENSATION COMMITTEE WHICH MEETS ANNUALLY TO REVIEW THE COMPENSATION OF THE CEO. THE COMPENSATION COMMITTEE DETERMINES THE CEO'S COMPENSATION BY UTILIZING DATA FROM COMPARABLY-SIZED ORGANIZATIONS (OBTAINED FORM 990 FILINGS). THE COMPENSATION DECISION IS DOCUMENTED IN THE RECORDS OF THE ORGANIZATION. SALARY INCREASES FOR KEY EMPLOYEES ARE RECOMMENDED BY THE CEO TO THE COMPENSATION COMMITTEE AFTER AN ANNUAL EVALUATION IS COMPLETED. THE COMPENSATION DECISION IS DOCUMENTED IN THE RECORDS OF THE ORGANIZATION.
FORM 990, PART VI, SECTION C, LINE 19FINANCIAL STATEMENTS ARE AVAILABLE ON OCRA'S WEBSITE. ALL OTHER DOCUMENTS ARE AVAILABLE UPON REQUEST.
FORM 990, PART XI, LINE 9:GRANT REFUNDS 262,392.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1OVARIAN CANCER NATIONAL ALLIANCEBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line11101 14TH STREET NW SUITE 850AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20005ZIPCd
FieldValueIRS element (for citing)
EIN311581756EIN
Primary ActivitiesEDUCATION AND ADVOCACYPrimaryActivitiesTxt
Legal Domicile StateDCLegalDomicileStateCd
Exempt Code Section501(C)(3)ExemptCodeSectionTxt
Public Charity StatusLINE 10PublicCharityStatusTxt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1THE OVARIAN CANCER RESEARCH FUND INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Controlled OrganizationYes (1)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.